Biointelect Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

  • Investments
  • 3

Biointelect General Information

Description

Provider of biopharmaceutical consulting services intended to develop and drive strategy. The company's services conduct detailed market evaluations and define optimum clinical, regulatory, reimbursement and market-entry strategies, enabling clients to identify opportunities and reduce risk as well as optimize commercial results for their bio-pharmaceutical product or medical device.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Level 4, 143 Macquarie Street
  • Sydney, New South Wales 2000
  • Australia
+61 1300
Primary Industry
Practice Management (Healthcare)
Other Industries
Biotechnology
Other Healthcare Services
Corporate Office
  • Level 4, 143 Macquarie Street
  • Sydney, New South Wales 2000
  • Australia
+61 1300

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biointelect Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biointelect‘s full profile, request access.

Request a free trial

Biointelect Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biointelect Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biointelect‘s full profile, request access.

Request a free trial

Biointelect Investments (3)

Biointelect’s most recent deal was a Accelerator/Incubator with Proboxis Biotechnology for . The deal was made on 21-Sep-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Proboxis Biotechnology 21-Sep-2026 Accelerator/Incubator Drug Discovery
Saccharide Therapeutics 01-Sep-2026 Accelerator/Incubator Biotechnology
Ena Respiratory 01-Jan-2026 Accelerator/Incubator Drug Discovery
To view Biointelect’s complete investments history, request access »

Biointelect FAQs

  • When was Biointelect founded?

    Biointelect was founded in 2011.

  • Where is Biointelect headquartered?

    Biointelect is headquartered in Sydney, Australia.

  • What is the size of Biointelect?

    Biointelect has 33 total employees.

  • What industry is Biointelect in?

    Biointelect’s primary industry is Practice Management (Healthcare).

  • Is Biointelect a private or public company?

    Biointelect is a Private company.

  • What is the current valuation of Biointelect?

    The current valuation of Biointelect is .

  • What is Biointelect’s current revenue?

    The current revenue for Biointelect is .

  • Who are Biointelect’s investors?

    Herz Family Trust has invested in Biointelect.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process